📰 Abt News
Page 115 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
August 18, 2023
Allstate Corp trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 90.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,922 shares of the healthcare product maker’s stock after selling 62,362 shares during the period. Allstate […]
August 18, 2023
First National Advisers LLC boosted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 37.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,997 shares of the healthcare product maker’s stock after purchasing an additional 3,809 shares during the […]
August 18, 2023
Arcblock (ABT) traded 7% lower against the U.S. dollar during the twenty-four hour period ending at 17:00 PM E.T. on August 18th. In the last seven days, Arcblock has traded 11.7% lower against the U.S. dollar. Arcblock has a market cap of $7.25 million and approximately $104,212.08 worth of Arcblock was traded on exchanges in […]
August 18, 2023
Woodley Farra Manion Portfolio Management Inc. lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,974 shares of the healthcare product maker’s stock after selling 100 shares during […]
August 17, 2023
Nelson Van Denburg & Campbell Wealth Management Group LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 59.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,509 shares of the healthcare product maker’s stock […]
August 17, 2023
Credit Suisse AG boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 4.6% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,653,173 shares of the healthcare product maker’s stock after purchasing an additional 116,350 shares during the period. Credit Suisse AG owned about […]
August 17, 2023
MAI Capital Management boosted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 0.2% in the 1st quarter, HoldingsChannel reports. The fund owned 376,267 shares of the healthcare product maker’s stock after acquiring an additional 640 shares during the quarter. MAI Capital Management’s holdings in Abbott Laboratories were worth $38,101,000 at the end of […]
August 17, 2023
Boston Research & Management Inc. raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% during the first quarter, Holdings Channel reports. The fund owned 59,594 shares of the healthcare product maker’s stock after buying an additional 590 shares during the period. Abbott Laboratories makes up approximately 1.8% of Boston Research & Management […]
August 17, 2023
Boston Research & Management Inc. boosted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 59,594 shares of the healthcare product maker’s stock after acquiring an additional 590 shares during the quarter. […]
August 17, 2023
Vestor Capital LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 80,347 shares of the healthcare product maker’s stock after selling 1,714 shares during […]